4
Changes in Ownership
HERON THERAPEUTICS, INC. /DE/ Filed Acc 0001209191-24-001626
VP, Chief Accounting Officer gave up 756 shares (to pay taxes)
- VP, Chief Accounting Officer acquired 1,841 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Peraza Lisa VP, Chief Accounting Officer | 2024-01-13 | Option exercise | +552 | 55,374 | D: show line 1 in the form | ||
| Peraza Lisa VP, Chief Accounting Officer | 2024-01-13 | Option exercise | +1,289 | 56,663 | D: show line 2 in the form | ||
| Peraza Lisa VP, Chief Accounting Officer | 2024-01-13 | Shares withheld for taxes | −756 | $2.15 | $1,625 | 55,907 | D: show line 3 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Peraza Lisa VP, Chief Accounting Officer | 2024-01-13 | Option exercise · Restricted Stock Units | −552 | 1,656 | D: show line 4 in the form | ||
| Peraza Lisa VP, Chief Accounting Officer | 2024-01-13 | Option exercise · Restricted Stock Units | −1,289 | 6,675 | D: show line 5 in the form |
Loading xslF345X05/doc4.xml…